Becton, Dickinson and Company (BDX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Becton Dickinson and Co BDX
$144.18
▼ -2.26%
($-3.33)
Index member:
S&P 500
Open
$146.59
Prev Close
$147.51
Day Range
$142.83 – $146.59
52W Range
$127.54 – $187.35
Market Cap
$39.44B
P/E (TTM)
34.90
Beta
0.22
Div Yield
2.85%
EPS (TTM)
$3.94
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 1963-09-25 |
| Shares Out. | 284,740,000 |
| Website | bd.com/ ↗ |
| Phone | 12018476800 |
Becton Dickinson and Co is a publicly traded company under the ticker symbol BDX on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
21 analysts (2026-05-01)
📰 Latest News for BDX
Transcript : Becton, Dickinson and Company Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 08
[Latest] Global Flexible Endoscope Market Size/Share Worth USD 22.7 Billion by 2035 at a 6% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Boston Scientific: Poised To Rebound With The Healthcare Sector, But When?
Barclays Maintains Overweight on Becton Dickinson, Raises Price Target to $204
Did BD’s Earnings Shift, Portfolio Sale and New CFO Just Recast Becton Dickinson’s (BDX) Investment Narrative?
Jim Cramer on Becton, Dickinson: “The Company Showed Excellent Execution Across the Board”
Becton, Dickinson and Company Q2 Earnings Call Highlights